STATE STREET CORP - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$133,160,207
+117.0%
3,468,617
+7.2%
0.01%
+133.3%
Q2 2023$61,352,186
-0.3%
3,234,169
-18.5%
0.00%0.0%
Q1 2023$61,537,554
-44.3%
3,967,605
-36.3%
0.00%0.0%
Q4 2022$110,509,476
+2153.9%
6,225,886
+608.6%
0.00%
Q3 2022$4,903,000
+40.9%
878,601
-1.6%
0.00%
Q2 2022$3,481,000
-24.4%
892,680
+6.8%
0.00%
Q1 2022$4,605,000
-80.6%
835,742
-70.0%
0.00%
-100.0%
Q4 2021$23,709,000
-33.6%
2,782,794
-32.3%
0.00%
-50.0%
Q3 2021$35,731,000
-23.0%
4,111,794
-6.4%
0.00%0.0%
Q2 2021$46,409,000
-20.0%
4,390,637
+21.4%
0.00%
-33.3%
Q1 2021$57,997,000
-32.8%
3,615,760
+93.5%
0.00%
-40.0%
Q4 2020$86,330,000
+113.1%
1,869,020
+62.3%
0.01%
+66.7%
Q3 2020$40,520,000
+401.9%
1,151,465
+247.3%
0.00%
+200.0%
Q2 2020$8,074,000331,5750.00%
Other shareholders
IMMUNOVANT INC shareholders Q3 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 4,448,017$17,347,0004.39%
Deep Track Capital, LP 9,455,000$36,875,0002.42%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 233$60,000,0000.63%
Octagon Capital Advisors LP 579,061$2,258,0000.60%
Eventide Asset Management 5,372,512$20,953,0000.45%
WITTENBERG INVESTMENT MANAGEMENT, INC. 174,000$679,0000.29%
Frazier Life Sciences Management, L.P. 585,759$2,284,0000.22%
BCK CAPITAL MANAGEMENT LP 54,293$212,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 777,590$3,033,0000.12%
Bridgefront Capital, LLC 15,649$61,0000.07%
View complete list of IMMUNOVANT INC shareholders